Bluebird’s CAR T-cell Therapy Shows Promise in Advanced Multiple Myeloma Patients
Patients with advanced multiple myeloma may benefit from bluebird…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Blood Purification Technique Could Offer Therapeutic Benefits for Multiple Myeloma
A technique called extracorporeal blood purification (EBP) could be used to remove certain molecules from the blood and potentially treat different conditions including multiple myeloma and kidney complications associated with it.
Extra Weight in Precancerous Stages Increases Risk of Multiple Myeloma, Study Finds
Patients in a precancerous stage of multiple myeloma would…
Ninlaro Granted Conditional Approval by European Commission to Treat Multiple Myeloma
The European Commission has granted conditional marketing authorization to…
Nonspecific Symptoms Including Back Pain Should Be Red Flags for Myeloma, Study Suggests
A combination of nonspecific symptoms, including back pain and…
FDA OKs Darzalex as Combination Therapy for Relapsed or Refractory Myeloma Patients
The U.S. Food and Drug Administration (FDA) has approved…
